311 related articles for article (PubMed ID: 21900290)
1. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
Qi Q; Workalemahu T; Zhang C; Hu FB; Qi L
Eur Heart J; 2012 Feb; 33(3):325-34. PubMed ID: 21900290
[TBL] [Abstract][Full Text] [Related]
2. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus.
Singh SS; Rashid M; Lieverse AG; Kronenberg F; Lamina C; Mulder MT; de Rijke YB; Sijbrands EJG; van Hoek M
Diabetologia; 2020 Jun; 63(6):1248-1257. PubMed ID: 32152647
[TBL] [Abstract][Full Text] [Related]
5. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
Zewinger S; Kleber ME; Tragante V; McCubrey RO; Schmidt AF; Direk K; Laufs U; Werner C; Koenig W; Rothenbacher D; Mons U; Breitling LP; Brenner H; Jennings RT; Petrakis I; Triem S; Klug M; Filips A; Blankenberg S; Waldeyer C; Sinning C; Schnabel RB; Lackner KJ; Vlachopoulou E; Nygård O; Svingen GFT; Pedersen ER; Tell GS; Sinisalo J; Nieminen MS; Laaksonen R; Trompet S; Smit RAJ; Sattar N; Jukema JW; Groesdonk HV; Delgado G; Stojakovic T; Pilbrow AP; Cameron VA; Richards AM; Doughty RN; Gong Y; Cooper-DeHoff R; Johnson J; Scholz M; Beutner F; Thiery J; Smith JG; Vilmundarson RO; McPherson R; Stewart AFR; Cresci S; Lenzini PA; Spertus JA; Olivieri O; Girelli D; Martinelli NI; Leiherer A; Saely CH; Drexel H; Mündlein A; Braund PS; Nelson CP; Samani NJ; Kofink D; Hoefer IE; Pasterkamp G; Quyyumi AA; Ko YA; Hartiala JA; Allayee H; Tang WHW; Hazen SL; Eriksson N; Held C; Hagström E; Wallentin L; Åkerblom A; Siegbahn A; Karp I; Labos C; Pilote L; Engert JC; Brophy JM; Thanassoulis G; Bogaty P; Szczeklik W; Kaczor M; Sanak M; Virani SS; Ballantyne CM; Lee VV; Boerwinkle E; Holmes MV; Horne BD; Hingorani A; Asselbergs FW; Patel RS; ; Krämer BK; Scharnagl H; Fliser D; März W; Speer T
Lancet Diabetes Endocrinol; 2017 Jul; 5(7):534-543. PubMed ID: 28566218
[TBL] [Abstract][Full Text] [Related]
6. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins.
Wei WQ; Li X; Feng Q; Kubo M; Kullo IJ; Peissig PL; Karlson EW; Jarvik GP; Lee MTM; Shang N; Larson EA; Edwards T; Shaffer CM; Mosley JD; Maeda S; Horikoshi M; Ritchie M; Williams MS; Larson EB; Crosslin DR; Bland HT; Pacheco JA; Rasmussen-Torvik LJ; Cronkite D; Hripcsak G; Cox NJ; Wilke RA; Stein CM; Rotter JI; Momozawa Y; Roden DM; Krauss RM; Denny JC
Circulation; 2018 Oct; 138(17):1839-1849. PubMed ID: 29703846
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
[TBL] [Abstract][Full Text] [Related]
8. Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study.
Xia J; Guo C; Liu K; Xie Y; Cao H; Peng W; Sun Y; Liu X; Li B; Zhang L
Lipids Health Dis; 2021 Jun; 20(1):57. PubMed ID: 34074296
[TBL] [Abstract][Full Text] [Related]
9. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia.
Paquette M; Bernard S; Thanassoulis G; Baass A
J Clin Lipidol; 2019; 13(4):627-633.e1. PubMed ID: 31103339
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels.
Emdin CA; Khera AV; Natarajan P; Klarin D; Won HH; Peloso GM; Stitziel NO; Nomura A; Zekavat SM; Bick AG; Gupta N; Asselta R; Duga S; Merlini PA; Correa A; Kessler T; Wilson JG; Bown MJ; Hall AS; Braund PS; Samani NJ; Schunkert H; Marrugat J; Elosua R; McPherson R; Farrall M; Watkins H; Willer C; Abecasis GR; Felix JF; Vasan RS; Lander E; Rader DJ; Danesh J; Ardissino D; Gabriel S; Saleheen D; Kathiresan S; ;
J Am Coll Cardiol; 2016 Dec; 68(25):2761-2772. PubMed ID: 28007139
[TBL] [Abstract][Full Text] [Related]
11. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
Wang L; Chen J; Zeng Y; Wei J; Jing J; Li G; Su L; Tang X; Wu T; Zhou L
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1989-96. PubMed ID: 27417586
[TBL] [Abstract][Full Text] [Related]
12. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.
Lu W; Cheng YC; Chen K; Wang H; Gerhard GS; Still CD; Chu X; Yang R; Parihar A; O'Connell JR; Pollin TI; Angles-Cano E; Quon MJ; Mitchell BD; Shuldiner AR; Fu M
Hum Mol Genet; 2015 Apr; 24(8):2390-400. PubMed ID: 25575512
[TBL] [Abstract][Full Text] [Related]
13. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
Burgess S; Ference BA; Staley JR; Freitag DF; Mason AM; Nielsen SF; Willeit P; Young R; Surendran P; Karthikeyan S; Bolton TR; Peters JE; Kamstrup PR; Tybjærg-Hansen A; Benn M; Langsted A; Schnohr P; Vedel-Krogh S; Kobylecki CJ; Ford I; Packard C; Trompet S; Jukema JW; Sattar N; Di Angelantonio E; Saleheen D; Howson JMM; Nordestgaard BG; Butterworth AS; Danesh J;
JAMA Cardiol; 2018 Jul; 3(7):619-627. PubMed ID: 29926099
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).
Deshmukh HA; Colhoun HM; Johnson T; McKeigue PM; Betteridge DJ; Durrington PN; Fuller JH; Livingstone S; Charlton-Menys V; Neil A; Poulter N; Sever P; Shields DC; Stanton AV; Chatterjee A; Hyde C; Calle RA; DeMicco DA; Trompet S; Postmus I; Ford I; Jukema JW; Caulfield M; Hitman GA
J Lipid Res; 2012 May; 53(5):1000-1011. PubMed ID: 22368281
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter.
Coassin S; Hermann-Kleiter N; Haun M; Wahl S; Wilson R; Paulweber B; Kunze S; Meitinger T; Strauch K; Peters A; Waldenberger M; Kronenberg F; Lamina C
PLoS One; 2020; 15(4):e0232073. PubMed ID: 32343731
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia.
Page MM; Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
Clin Chim Acta; 2020 Nov; 510():211-215. PubMed ID: 32681934
[TBL] [Abstract][Full Text] [Related]
17. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction.
Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
J Am Coll Cardiol; 2013 Mar; 61(11):1146-56. PubMed ID: 23375930
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.
Ronald J; Rajagopalan R; Cerrato F; Nord AS; Hatsukami T; Kohler T; Marcovina S; Heagerty P; Jarvik GP
Stroke; 2011 Jan; 42(1):2-9. PubMed ID: 21127300
[TBL] [Abstract][Full Text] [Related]
19. Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.
Perrot N; Verbeek R; Sandhu M; Boekholdt SM; Hovingh GK; Wareham NJ; Khaw KT; Arsenault BJ
Atherosclerosis; 2017 Jan; 256():47-52. PubMed ID: 27998826
[TBL] [Abstract][Full Text] [Related]
20. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
